Why Biotech and FinTech Are Primed for SPAC Deals

In this episode of The SPAC Podcast, Adeel Rouf dives into two of his highest-conviction sectors for upcoming SPAC activity: healthcare (specifically biotech) and FinTech. While AI and crypto dominate the headlines, Adeel makes the case for why some of the most overlooked, and deeply discounted, opportunities exist in these quieter corners of the market.Biotech, he notes, has been heavily discounted since the market cooled in 2021–2023, leaving many high-quality companies undervalued and ready for smart capital. Meanwhile, the rapid evolution of digital assets and payment platforms makes FinTech a sector full of momentum. With SPACs already positioned in both verticals, Adeel outlines why these areas could lead the next wave of smart public listings.Connect with the Guest:Adeel Rouf – SPAC Sponsor & InvestorLinkedIn: https://www.linkedin.com/in/adeelrouf/View all of their episodes here:https://www.thespacpodcast.com/guests/adeel-rouf/Connect with the Hosts & The SPAC Podcast:Michael Blankenship LinkedIn:https://www.linkedin.com/in/mikeblankenship/Joshua Wilson LinkedIn:https://www.linkedin.com/in/joshuabrucewilson/YouTube Channel:https://www.youtube.com/@ThespacpodcastContact The SPAC Podcast:https://www.thespacpodcast.com/contact/#SPACs #CapitalMarkets #SPACPodcast #Biotech #FinTech #SPACDeals #IPOAlternativesThe views, opinions, and statements expressed by the guest are solely their own and do not necessarily reflect the views of The SPAC Podcast, its hosts, or affiliated organizations. This content is for informational purposes only and should not be construed as investment, legal, tax, or accounting advice.Disclaimer: Michael J. Blankenship is a licensed attorney and partner at Winston Taylor. Joshua Wilson is a licensed Florida real estate broker and holds FINRA Series 79 and Series 63 licensure. The content of this podcast is for informational and educational purposes only and should not be considered legal, financial, or compliance advice. All views and opinions expressed by the hosts and guests are their own and do not necessarily reflect the policies or positions of any regulatory agency, law firm, organization, or employer. Listeners should consult their own legal counsel, compliance teams, or financial advisors to ensure adherence to applicable regulations, including SEC, FINRA, and other industry-specific requirements. This podcast does not constitute a solicitation or recommendation for any financial products or services.Let's Connect on LinkedIn: https://www.linkedin.com/in/mikeblankenship/ https://www.linkedin.com/in/joshuabrucewilson/ To Contact Us, Please Visit: https://www.TheSPACPodcast.com/contact/